From a backup technology to a strategy-outlining approach: The success story of cryopreservation

Expert Review of Obstetrics and Gynecology

Volumn 8, Issue 2, 2013, Pages 181-190

  Vajta, Gábor ^a   Reichart, Anikó ^b   Ubaldi, Filippo ^c   Rienzi, Laura ^c  

^a CENTRAL QUEENSLAND UNIVERSITY   (Australia)

^b Forgács Institute   (Hungary)

^c GENERA Centre for Reproductive Medicine   (Italy)

Author keywords

cryopreservation; embryo; freezing; oocyte; PGD; pregnancy; vitrification

Indexed keywords

APPLIED RESEARCH; AUTOMATION; BIOPSY TECHNIQUE; BLASTOCYST; BLASTOCYTE; CELL MANIPULATION; CLINICAL EFFECTIVENESS; COLD TOLERANCE; COOLING; CRYOPRESERVATION; FREEZE THAWING; HUMAN; INFERTILITY THERAPY; INVESTMENT; JOB PERFORMANCE; LEGAL ASPECT; MASS MEDIUM; NONHUMAN; OOCYTE; PREGNANCY OUTCOME; REVIEW; SAFETY; SCIENTIST; STANDARDIZATION; SURVIVAL RATE; TREATMENT PLANNING;

EID: 84874636841     PISSN: 17474108     EISSN: 17474116     Source Type: Journal    
DOI: 10.1586/eog.12.80     Document Type: Review

References (85)

1. Leibo SP, Pool TB. The principal variables of cryopreservation: solutions, temperatures, and rate changes. Fertil. Steril. 96(2), 269-276 (2011).
2. Smith GD, Motta EE, Serafini P. Theoretical and experimental basis of oocyte vitrification. Reprod. Biomed. Online 23(3), 298-306 (2011).
3. Herrero L, Martínez M, Garcia-Velasco JA. Current status of human oocyte and embryo cryopreservation. Curr. Opin. Obstet. Gynecol. 23(4), 245-250 (2011).
4. Boldt J. Current results with slow freezing and vitrification of the human oocyte. Reprod. Biomed. Online 23(3), 314-322 (2011).
5. Vajta G. Vitrification in human and domestic animal embryology: work in progress. Reprod. Fertil. Dev. doi:org/10.1071/RD12118 (2012) (Epub ahead of print).
6. Edgar DH, Gook DA. A critical appraisal of cryopreservation (slow cooling versus vitrification) of human oocytes and embryos. Hum. Reprod. Update 18(5), 536-554 (2012).
7. Nagy ZP, Chang CC, Shapiro DB, Bernal DP, Kort HI, Vajta G. The efficacy and safety of human oocyte vitrification. Semin. Reprod. Med. 27(6), 450-455 (2009).
8. Vajta G, Nagy ZP. Are programmable freezers still needed in the embryo laboratory? Review on vitrification. Reprod. Biomed. Online 12(6), 779-796 (2006).
9. Shaw JM, Jones GM. Terminology associated with vitrification and other cryopreservation procedures for oocytes and embryos. Hum. Reprod. Update 9(6), 583-605 (2003).
10. Rall WF, Fahy GM. Ice-free cryopreservation of mouse embryos at-196 degrees C by vitrification. Nature 313(6003), 573-575 (1985).
11. Vanderzwalmen P, Delval A, Chatzipoarasidou A et al. Pregnancies after vitrification of human day 5 embryos. Hum. Reprod. 12(Suppl.), 98 (1997).
12. Mukaida T, Wada S, Takahashi K, Pedro PB, An TZ, Kasai M. Vitrification of human embryos based on the assessment of suitable conditions for 8-cell mouse embryos. Hum. Reprod. 13(10), 2874-2879 (1998).
13. Kuleshova L, Gianaroli L, Magli C, Ferraretti A, Trounson A. Birth following vitrification of a small number of human oocytes: case report. Hum. Reprod. 14(12), 3077-3079 (1999).
14. Yokota Y, Sato S, Yokota M et al. Successful pregnancy following blastocyst vitrification: case report. Hum. Reprod. 15(8), 1802-1803 (2000).
15. Vanderzwalmen P, Zech N, Lejeune B, Wirtleitner B, Zech M, Ectors F. Vitrification and the use of high concentrations of cryoprotectants: is it a justified argument to prefer slow freezing? Gynecol. Obstet. Fertil. 38(9), 536-540 (2010).
16. Kartberg AJ, Hambiliki F, Arvidsson T, Stavreus-Evers A, Svalander P. Vitrification with DMSO protects embryo membrane integrity better than solutions without DMSO. Reprod. Biomed. Online 17(3), 378-384 (2008).
17. Aye M, Di Giorgio C, De Mo M, Botta A, Perrin J, Courbiere B. Assessment of the genotoxicity of three cryoprotectants used for human oocyte vitrification: dimethyl sulfoxide, ethylene glycol and propylene glycol. Food Chem. Toxicol. 48(7), 1905-1912 (2010).
18. Almansoori KA, Prasad V, Forbes JF et al. Cryoprotective agent toxicity interactions in human articular chondrocytes. Cryobiology 64(3), 185-191 (2012).
19. Lawson A, Ahmad H, Sambanis A. Cytotoxicity effects of cryoprotectants as single-component and cocktail vitrification solutions. Cryobiology 62(2), 115-122 (2011).
20. Cobo A, Diaz C. Clinical application of oocyte vitrification: a systematic review and meta-analysis of randomized controlled trials. Fertil. Steril. 96(2), 277-285 (2011).
21. Cobo A, de los Santos MJ, Castello D, Gamiz P, Campos P, Remohi J. Outcomes of vitrified early cleavage-stage and blastocyst-stage embryos in a cryopreservation program: evaluation of 3,150 warming cycles. Fertil. Steril. 98(5), 1138-1146 (2012).
22. Sifer C, Sermondade N, Dupont C et al. [Outcome of embryo vitrification compared to slow freezing process at early cleavage stages. Report of the first French birth]. Gynecol. Obstet. Fertil. 40(3), 158-161 (2012).
23. Bianchi V, Lappi M, Bonu MA, Borini A. Oocyte slow freezing using a 0.2-0.3 M sucrose concentration protocol: is it really the time to trash the cryopreservation machine? Fertil. Steril. 97(5), 1101-1107 (2012).
24. De Santis L, Coticchio G. Theoretical and experimental basis of slow freezing. Reprod. Biomed. Online 22(2), 125-132 (2011).
25. Martínez-Burgos M, Herrero L, Megías D et al. Vitrification versus slow freezing of oocytes: effects on morphologic appearance, meiotic spindle configuration, and DNA damage. Fertil. Steril. 95(1), 374-377 (2011).
26. AbdelHafez FF, Desai N, Abou-Setta AM, Falcone T, Goldfarb J. Slow freezing, vitrification and ultra-rapid freezing of human embryos: a systematic review and meta-analysis. Reprod. Biomed. Online 20(2), 209-222 (2010).
27. Loutradi KE, Kolibianakis EM, Venetis CA et al. Cryopreservation of human embryos by vitrification or slow freezing: a systematic review and meta-analysis. Fertil. Steril. 90(1), 186-193 (2008).
28. Noyes N, Porcu E, Borini A. Over 900 oocyte cryopreservation babies born with no apparent increase in congenital anomalies. Reprod. Biomed. Online 18(6), 769-776 (2009).
29. Chian RC, Huang JY, Gilbert L et al. Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes. Fertil. Steril. 91(6), 2391-2398 (2009).
30. Kato O, Kawasaki N, Bodri D et al. Neonatal outcome and birth defects in 6623 singletons born following minimal ovarian stimulation and vitrified versus fresh single embryo transfer. Eur. J. Obstet. Gynecol. Reprod. Biol. 161(1), 46-50 (2012).
31. Pinborg A. To transfer fresh or thawed embryos? Semin. Reprod. Med. 30(3), 230-235 (2012).
32. Bonetti A, Cervi M, Tomei F, Marchini M, Ortolani F, Manno M. Ultrastructural evaluation of human metaphase II oocytes after vitrification: closed versus open devices. Fertil. Steril. 95(3), 928-935 (2011).
33. Cobo A, Meseguer M, Remohí J, Pellicer A. Use of cryo-banked oocytes in an ovum donation programme: a prospective, randomized, controlled, clinical trial. Hum. Reprod. 25(9), 2239-2246 (2010).
34. Cobo A, Kuwayama M, Pérez S, Ruiz A, Pellicer A, Remohí J. Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil. Steril. 89(6), 1657-1664 (2008).
35. Rienzi L, Romano S, Albricci L et al. Embryo development of fresh 'versus' vitrified metaphase II oocytes after ICSI: a prospective randomized sibling-oocyte study. Hum. Reprod. 25(1), 66-73 (2010).
36. García JI, Noriega-Portella L, Noriega-Hoces L. Efficacy of oocyte vitrification combined with blastocyst stage transfer in an egg donation program. Hum. Reprod. 26(4), 782-790 (2011).
37. Trokoudes KM, Pavlides C, Zhang X. Comparison outcome of fresh and vitrified donor oocytes in an egg-sharing donation program. Fertil. Steril. 95(6), 1996-2000 (2011).
38. Parmegiani L, Cognigni GE, Bernardi S et al. Efficiency of aseptic open vitrification and hermetical cryostorage of human oocytes. Reprod. Biomed. Online 23(4), 505-512 (2011).
39. Lucena E, Bernal DP, Lucena C, Rojas A, Moran A, Lucena A. Successful ongoing pregnancies after vitrification of oocytes. Fertil. Steril. 85(1), 108-111 (2006).
40. Antinori M, Licata E, Dani G, Cerusico F, Versaci C, Antinori S. Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod. Biomed. Online 14(1), 72-79 (2007).
41. Ubaldi F, Anniballo R, Romano S et al. Cumulative ongoing pregnancy rate achieved with oocyte vitrification and cleavage stage transfer without embryo selection in a standard infertility program. Hum. Reprod. 25(5), 1199-1205 (2010).
42. Forman EJ, Li X, Ferry KM, Scott K, Treff NR, Scott RT Jr. Oocyte vitrification does not increase the risk of embryonic aneuploidy or diminish the implantation potential of blastocysts created after intracytoplasmic sperm injection: a novel, paired randomized controlled trial using DNA fingerprinting. Fertil. Steril. 98(3), 644-649 (2012).
43. Di Pietro C, Vento M, Guglielmino MR et al. Molecular profiling of human oocytes after vitrification strongly suggests that they are biologically comparable with freshly isolated gametes. Fertil. Steril. 94(7), 2804-2807 (2010).
44. Kuwayama M, Vajta G, Ieda S, Kato O. Comparison of open and closed methods for vitrification of human embryos and the elimination of potential contamination. Reprod. Biomed. Online 11(5), 608-614 (2005).
45. Kansal Kalra S, Ratcliffe SJ, Milman L, Gracia CR, Coutifaris C, Barnhart KT. Perinatal morbidity after in vitro fertilization is lower with frozen embryo transfer. Fertil. Steril. 95(2), 548-553 (2011).
46. Check JH, Summers-Chase D, Yuan W, Swenson K, Horwath D. Length of time of embryo storage does not negatively influence pregnancy rates after thawing and transfer. Clin. Exp. Obstet. Gynecol. 37(3), 185-186 (2010).
47. Wilson C, Check JH, Summers-Chase D, Choe JK, Amui J, Brasile D. Effect of the length of time that donated embryos are frozen on pregnancy outcome. Clin. Exp. Obstet. Gynecol. 37(3), 181-182 (2010).
48. Dowling-Lacey D, Mayer JF, Jones E, Bocca S, Stadtmauer L, Oehninger S. Live birth from a frozen-thawed pronuclear stage embryo almost 20 years after its cryopreservation. Fertil. Steril. 95(3), 1120.e1-1120.e3 (2011).
49. Kim TJ, Hong SW. Successful live birth from vitrified oocytes after 5 years of cryopreservation. J. Assist. Reprod. Genet. 28(1), 73-76 (2011).
50. Rudick B, Opper N, Paulson R, Bendikson K, Chung K. The status of oocyte cryopreservation in the United States. Fertil. Steril. 94(7), 2642-2646 (2010).
51. Liu KE, Greenblatt EM. Oocyte cryopreservation in Canada: a survey of Canadian ART clinics. J. Obstet. Gynaecol. Can. 34(3), 250-256 (2012).
52. Lockwood GM. Social egg freezing: the prospect of reproductive 'immortality' or a dangerous delusion? Reprod. Biomed. Online 23(3), 334-340 (2011).
53. Dondorp W, de Wert WG, Pennings G et al. Oocyte cryopreservation for age-related fertility loss. Hum. Reprod. 27, 1231-1237 (2012).
54. Rienzi L, Cobo A, Paffoni A et al. Consistent and predictable delivery rates after oocyte vitrification: an observational longitudinal cohort multicentric study. Hum. Reprod. 27(6), 1601-1612 (2012).
55. Cobo A, Remohí J, Chang CC, Nagy ZP. Oocyte cryopreservation for donor egg banking. Reprod. Biomed. Online 23(3), 341-346 (2011).
56. Borini A, Suriano R, Barberi M, Dal Prato L, Bulletti C. Oocyte donation programs: strategy for improving results. Ann. NY Acad. Sci. 1221, 27-31 (2011).
57. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfer in normal responders. Fertil. Steril. 96(2), 344-348 (2011).
58. Shapiro BS, Daneshmand ST, Garner FC, Aguirre M, Hudson C, Thomas S. Evidence of impaired endometrial receptivity after ovarian stimulation for in vitro fertilization: a prospective randomized trial comparing fresh and frozen-thawed embryo transfers in high responders. Fertil. Steril. 96(2), 516-518 (2011).
59. Zhu D, Zhang J, Cao S et al. Vitrifiedwarmed blastocyst transfer cycles yield higher pregnancy and implantation rates compared with fresh blastocyst transfer cycles-time for a new embryo transfer strategy? Fertil. Steril. 95(5), 1691-1695 (2011).
60. Chang EM, Han JE, Kim YS, Lyu SW, Lee WS, Yoon TK. Use of the natural cycle and vitrification thawed blastocyst transfer results in better in-vitro fertilization outcomes: cycle regimens of vitrification thawed blastocyst transfer. J. Assist. Reprod. Genet. 28(4), 369-374 (2011).
61. Xiao Z, Zhou X, Xu W, Yang J, Xie Q. Natural cycle is superior to hormone replacement therapy cycle for vitrificatedpreserved frozen-thawed embryo transfer. Syst. Biol. Reprod. Med. 58(2), 107-112 (2012).
62. Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a 'freeze-all' strategy: a prospective multicentric study. Fertil. Steril. 95(6), 2029-2033, 2033.e1 (2011).
63. D'Angelo A. Ovarian hyperstimulation syndrome prevention strategies: cryopreservation of all embryos. Semin. Reprod. Med. 28(6), 513-518 (2010).
64. Ishihara O, Kuwahara A, Saitoh H. Frozen-thawed blastocyst transfer reduces ectopic pregnancy risk: an analysis of single embryo transfer cycles in Japan. Fertil. Steril. 95(6), 1966-1969 (2011).
65. Schwarze JE, Balmaceda J, Pommer R. Cryopreservation in blastocyst stage effectively reduce the number of embryos cryopreserved. Rev. Med. Chil. 140(1), 45-49 (2012).
66. Vanderzwalmen P, Bertin G, Debauche CH et al. Births after vitrification at morula and blastocyst stages: effect of artificial reduction of the blastocoelic cavity before vitrification. Hum. Reprod. 17(3), 744-751 (2002).
67. Son WY, Yoon SH, Yoon HJ, Lee SM, Lim JH. Pregnancy outcome following transfer of human blastocysts vitrified on electron microscopy grids after induced collapse of the blastocoele. Hum. Reprod. 18(1), 137-139 (2003).
68. Feng GX, Zhang B, Shu JH et al. Effects of artificial shrinkage of blastocoeles before vitrification on pregnancy outcome. Zhonghua Fu Chan Ke Za Zhi 45(11), 838-842 (2010).
69. Iwayama H, Hochi S, Yamashita M. In vitro and in vivo viability of human blastocysts collapsed by laser pulse or osmotic shock prior to vitrification. J. Assist. Reprod. Genet. 28(4), 355-361 (2011).
70. Mukaida T, Oka C, Goto T, Takahashi K. Artificial shrinkage of blastocoeles using either a micro-needle or a laser pulse prior to the cooling steps of vitrification improves survival rate and pregnancy outcome of vitrified human blastocysts. Hum. Reprod. 21(12), 3246-3252 (2006).
71. Debrock S, Peeraer K, Spiessens C, Willemen D, De Loecker P, D'Hooghe TM. The effect of modified quarter laser-assisted zona thinning on the implantation rate per embryo in frozen/vitrified-thawed/warmed embryo transfer cycles: a prospective randomized controlled trial. Hum. Reprod. 26(8), 1997-2007 (2011).
72. Vanderzwalmen P, Bertin G, Debauche CH et al. Vitrification of human blastocysts with the Hemi-Straw carrier: application of assisted hatching after thawing. Hum. Reprod. 18(7), 1504-1511 (2003).
73. Fragouli E, Wells D. Aneuploidy screening for embryo selection. Semin. Reprod. Med. 30(4), 289-301 (2012).
74. Harper JC, Sengupta SB. Preimplantation genetic diagnosis: state of the art 2011. Hum. Genet. 131(2), 175-186 (2012).
75. Xu K, Montag M. New perspectives on embryo biopsy: not how, but when and why? Semin. Reprod. Med. 30(4), 259-266 (2012).
76. Scott RT, Tao X, Taylor D, Ferry KM, Treff NR. A prospective randomized controlled trial demonstrating significantly increased clinical pregnancy rates following chromosome aneuploidy screening: biopsy and analysis on day 5 with fresh transfer. Fertil. Steril. 94, S2 (2010).
77. Forman EJ, Tao X, Ferry KM, Taylor D, Treff NR, Scott RT Jr. Single embryo transfer with comprehensive chromosome screening results in improved ongoing pregnancy rates and decreased miscarriage rates. Hum. Reprod. 27(4), 1217-1222 (2012).
78. Keskintepe L, Sher G, Machnicka A et al. Vitrification of human embryos subjected to blastomere biopsy for pre-implantation genetic screening produces higher survival and pregnancy rates than slow freezing. J. Assist. Reprod. Genet. 26(11-12), 629-635 (2009).
79. Schoolcraft WB, Treff NR, Stevens JM, Ferry K, Katz-Jaffe M, Scott RT Jr. Live birth outcome with trophectoderm biopsy, blastocyst vitrification, and singlenucleotide polymorphism microarray-based comprehensive chromosome screening in infertile patients. Fertil. Steril. 96(3), 638-640 (2011).
80. Harper J, Magli MC, Lundin K, Barratt CL, Brison D. When and how should new technology be introduced into the IVF laboratory? Hum. Reprod. 27(2), 303-313 (2012).
81. Brezis M, Malkiel A, Chinitz D, Lehmann LS. Discordant views of experts and laypersons on the adoption of new fertility technology. Med. Care 49(4), 420-423 (2011).
82. Pribenszky C, Vajta G, Molnar M et al. Stress for stress tolerance? A fundamentally new approach in mammalian embryology. Biol. Reprod. 83(5), 690-697 (2010).
83. Pribenszky C, Vajta G. Cells under pressure: how sublethal hydrostatic pressure stress treatment increases gametes' and embryos' performance. Reprod. Fertil. Dev. 23(1), 48-55 (2011).
84. Pribenszky C, Lin L, Du Y, Losonczi E, Dinnyes A, Vajta G. Controlled stress improves oocyte performance-cell preconditioning in assisted reproduction. Reprod. Domest. Anim. 47(Suppl. 4), 197-206 (2012).
85. Reichart A, Uhereczky G, Sipos M, Forgacs V, Vajta G. Progress towards a universal warming method after vitrification. Presented at: 16th World Congress on In Vitro Fertilization. Tokyo, Japan, 10-13 September 2011.